Overview

Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether the ICDs(Impulse Control Disorder) are improved and neuropsychiatric traits related to ICD are changed or not when switching dopamine agonist to levodopa/carbidopa in patients with Parkinson's disease who have been treated with dopaminergic medications.
Phase:
Phase 4
Details
Lead Sponsor:
Sandoz
Treatments:
Carbidopa
Dopamine
Dopamine Agonists
Levodopa